Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

INCREASED CHITOTRIOSIDASE IS ASSOCIATED WITH ASPERGILLUS AND FREQUENT EXACERBATIONS IN SOUTH-EAST ASIANS WITH BRONCHIECTASIS.

Poh TY, Tiew PY, Hou Lim AY, Thng KX, Binte Mohamed Ali NA, Narayana JK, Aogáin MM, Tien Z, Chew WM, Wai Chan AK, Keir HR, Dicker AJ, Hassan TM, Xu H, Tee AKH, Ong TH, Koh MS, Abisheganaden JA, Chalmers JD, Chotirmall SH.

Chest. 2020 Mar 14. pii: S0012-3692(20)30446-3. doi: 10.1016/j.chest.2020.02.048. [Epub ahead of print]

PMID:
32184111
2.

Early Career Members at the Lung Science Conference and the Sleep and Breathing Conference 2019.

Almendros I, El-Merhie N, Jha A, Keir HR, Lykouras D, Mahmutovic Persson I, Ubags ND, Bartel S.

Breathe (Sheff). 2019 Sep;15(3):234-240. doi: 10.1183/20734735.0203-2019.

3.

Antimicrobial peptides, disease severity and exacerbations in bronchiectasis.

Sibila O, Perea L, Cantó E, Shoemark A, Cassidy D, Smith AH, Suarez-Cuartin G, Rodrigo-Troyano A, Keir HR, Oriano M, Ong S, Vidal S, Blasi F, Aliberti S, Chalmers JD.

Thorax. 2019 Sep;74(9):835-842. doi: 10.1136/thoraxjnl-2018-212895. Epub 2019 Jul 5.

PMID:
31278172
4.

Pregnancy Zone Protein Is Associated with Airway Infection, Neutrophil Extracellular Trap Formation, and Disease Severity in Bronchiectasis.

Finch S, Shoemark A, Dicker AJ, Keir HR, Smith A, Ong S, Tan B, Choi JY, Fardon TC, Cassidy D, Huang JTJ, Chalmers JD.

Am J Respir Crit Care Med. 2019 Oct 15;200(8):992-1001. doi: 10.1164/rccm.201812-2351OC.

5.

A point-of-care neutrophil elastase activity assay identifies bronchiectasis severity, airway infection and risk of exacerbation.

Shoemark A, Cant E, Carreto L, Smith A, Oriano M, Keir HR, Perea L, Canto E, Terranova L, Vidal S, Moffitt K, Aliberti S, Sibila O, Chalmers JD.

Eur Respir J. 2019 Jun 13;53(6). pii: 1900303. doi: 10.1183/13993003.00303-2019. Print 2019 Jun.

6.

Airway Bacterial Load and Inhaled Antibiotic Response in Bronchiectasis.

Sibila O, Laserna E, Shoemark A, Keir HR, Finch S, Rodrigo-Troyano A, Perea L, Lonergan M, Goeminne PC, Chalmers JD.

Am J Respir Crit Care Med. 2019 Jul 1;200(1):33-41. doi: 10.1164/rccm.201809-1651OC.

PMID:
31109172
7.

Personalised anti-inflammatory therapy for bronchiectasis and cystic fibrosis: selecting patients for controlled trials of neutrophil elastase inhibition.

Keir HR, Fong CJ, Crichton ML, Barth P, Chevalier E, Brady G, Kennedy G, Zimmermann J, Bruijnzeel PLB, Dicker AJ, Chalmers JD.

ERJ Open Res. 2019 Mar 25;5(1). pii: 00252-2018. doi: 10.1183/23120541.00252-2018. eCollection 2019 Feb.

8.

Circulating desmosine as a biomarker of azithromycin treatment response: a post hoc analysis of the COLUMBUS randomised controlled trial.

Chalmers JD, Djamin RS, Schouten M, Keir HR, Tan B, Aerts JGJV, Huang JT, van der Eerden M.

ERJ Open Res. 2018 Nov 12;4(4). pii: 00136-2018. doi: 10.1183/23120541.00136-2018. eCollection 2018 Oct.

9.

Distinct "Immunoallertypes" of Disease and High Frequencies of Sensitization in Non-Cystic Fibrosis Bronchiectasis.

Mac Aogáin M, Tiew PY, Lim AYH, Low TB, Tan GL, Hassan T, Ong TH, Pang SL, Lee ZY, Gwee XW, Martinus C, Sio YY, Matta SA, Ong TC, Tiong YS, Wong KN, Narayanan S, Au VB, Marlier D, Keir HR, Tee A, Abisheganaden JA, Koh MS, Wang Y, Connolly JE, Chew FT, Chalmers JD, Chotirmall SH.

Am J Respir Crit Care Med. 2019 Apr 1;199(7):842-853. doi: 10.1164/rccm.201807-1355OC.

PMID:
30265843
10.

Immunological corollary of the pulmonary mycobiome in bronchiectasis: the CAMEB study.

Mac Aogáin M, Chandrasekaran R, Lim AYH, Low TB, Tan GL, Hassan T, Ong TH, Hui Qi Ng A, Bertrand D, Koh JY, Pang SL, Lee ZY, Gwee XW, Martinus C, Sio YY, Matta SA, Chew FT, Keir HR, Connolly JE, Abisheganaden JA, Koh MS, Nagarajan N, Chalmers JD, Chotirmall SH.

Eur Respir J. 2018 Jul 27;52(1). pii: 1800766. doi: 10.1183/13993003.00766-2018. Print 2018 Jul.

11.

10 years since TORCH: shining a new light on the risks of inhaled corticosteroids in COPD.

Chalmers JD, Keir HR.

Eur Respir J. 2017 Sep 20;50(3). pii: 1701582. doi: 10.1183/13993003.01582-2017. Print 2017 Sep. No abstract available.

12.

Profile of the ProAxsis active neutrophil elastase immunoassay for precision medicine in chronic respiratory disease.

Keir HR, Fong CJ, Dicker AJ, Chalmers JD.

Expert Rev Mol Diagn. 2017 Oct;17(10):875-884. doi: 10.1080/14737159.2017.1374174. Epub 2017 Sep 7.

PMID:
28854829
13.

The past decade in bench research into pulmonary infectious diseases: What do clinicians need to know?

Finch S, Keir HR, Dicker AJ, Chalmers JD.

Respirology. 2017 Aug;22(6):1062-1072. doi: 10.1111/resp.13106. Epub 2017 Jun 28. Review.

Supplemental Content

Support Center